The Efficacy of Shielding Systems for Reducing Operator Exposure during Neurointerventional Procedures: A Real-World Prospective Study

被引:2
|
作者
Miller, T. R. [1 ,2 ]
Zhuo, J. [1 ,2 ]
Jindal, G. [1 ,2 ]
Shivashankar, R. [1 ,2 ]
Beaty, N. [3 ]
Gandhi, D. [1 ,2 ]
机构
[1] Univ Maryland, Med Ctr, Dept Diagnost Radiol, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Dept Neuroradiol, Baltimore, MD 21201 USA
[3] Univ Maryland, Med Ctr, Dept Neurosurg, Baltimore, MD 21201 USA
关键词
RADIATION-ABSORBING SHIELD; INTERVENTIONAL NEURORADIOLOGY; DOSE REDUCTION; PATIENT; ANGIOGRAPHY; DRAPE; STERILE; TUMORS; BRAIN; RISK;
D O I
10.3174/ajnr.A5038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Neurointerventional surgery may expose patients and physician operators to substantial amounts of ionizing radiation. Although strategies for reducing patient exposure have been explored in the medical literature, there has been relatively little published in regards to decreasing operator exposure. The purpose of this study was to evaluate the efficacy of shielding systems in reducing physician exposure in a modern neurointerventional practice. MATERIALS AND METHODS: Informed consent was obtained from operators for this Health Insurance Portability and Accountability Act-compliant, institutional review board-approved study. Operator radiation exposure was prospectively measured during 60 consecutive neurointerventional procedures from October to November 2013 using a 3-part lead shielding system. Exposure was then evaluated without lead shielding in a second 60-procedure block from April to May 2014. A radiation protection drape was randomly selected for use in half of the cases in each block. Two-way analysis of covariance was performed to test the effect of shielding systems on operator exposure while controlling for other covariates, including procedure dose-area product. RESULTS: Mean operator procedure dose was 20.6 Sv for the entire cohort and 17.7 Sv when using some type of shielding. Operator exposure significantly correlated with procedure dose-area product, but not with other covariates. After we adjusted for procedure dose-area product, the use of lead shielding or a radiation protection drape significantly reduced operator exposure by 45% (F = 12.54, P < .0001) and 29% (F = 7.02, P = .009), respectively. The difference in protection afforded by these systems was not statistically significant (P = .46), and their adjunctive use did not provide additional protection. CONCLUSIONS: Extensive lead shielding should be used as much as possible in neurointerventional surgery to reduce operator radiation exposure to acceptable levels. A radiation protection drape is a reasonable alternative when standard lead shielding is unavailable or impractical to use without neglecting strategies to minimize the dose.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 50 条
  • [1] Fluoroscopy markers for minimizing patient and operator radiation exposure during neurointerventional procedures: a call to arms
    McGillen, Kathryn L.
    Jayaraman, Mahesh V.
    Haas, Richard A.
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2011, 3 (04) : 312 - 313
  • [2] Prospective multicenter observational real-world study to assess the use, efficacy and safety profile of follitropin delta during IVF/ICSI procedures (DELTA Study)
    Porcu-Buisson, Geraldine
    Maignien, Chloe
    Swierkowski-Blanchard, Nelly
    Rongieres, Catherine
    Ranisavljevic, Noemie
    Oger, Pierre
    Decanter, Christine
    Hocke, Claude
    Bry-Gauillard, Helene
    Grynberg, Michae l
    Barriere, Paul
    Bernot, Mathilde
    Guivarc'h-Leveque, Anne
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 293 : 21 - 26
  • [3] Radiation exposure during neurointerventional procedures in modern angiographic systems: A single center experience
    Lukic, Snezana
    Rasulic, Lukas
    Kovacevic, Vojin
    Vitosevic, Filip
    Savic, Andrija
    Mijailovic, Milan
    VOJNOSANITETSKI PREGLED, 2020, 77 (09) : 962 - 966
  • [4] Apremilast in psoriasis - a prospective real-world study
    Vujic, I.
    Herman, R.
    Sanlorenzo, M.
    Posch, C.
    Monshi, B.
    Rappersberger, K.
    Richter, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S195 - S195
  • [5] Apremilast in psoriasis - a prospective real-world study
    Vujic, I.
    Herman, R.
    Sanlorenzo, M.
    Posch, C.
    Monshi, B.
    Rappersberger, K.
    Richter, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (02) : 254 - 259
  • [6] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Neurocognitive Systems Related to Real-World Prospective Memory
    Kalpouzos, Gregoria
    Eriksson, Johan
    Sjolie, Daniel
    Molin, Jonas
    Nyberg, Lars
    PLOS ONE, 2010, 5 (10):
  • [8] Real-World Reductions in Lead-Free Radiation Exposure with the Rampart System during Endovascular Procedures
    Herzig, Matthew S.
    Kochar, Ajar
    Hermiller, James B.
    Davies, Rhian E.
    Nicholson, William J.
    Orui, Hibiki
    Secemsky, Eric. A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 243 : 59 - 64
  • [9] Real-World Reductions in Lead-Free Radiation Exposure With the Rampart System During Endovascular Procedures
    Herzig, Matthew
    Kochar, Ajar
    Hermiller, James
    Davies, Rhian
    Orui, Hibiki
    Nicholson, William
    Secemsky, Eric
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B297 - B297
  • [10] Efficacy and safety of the perclose closer S device after neurointerventional procedures: Prospective study and literature review
    Khaghany, K
    Al-Ali, F
    Spigelmoyer, T
    Pimentel, R
    Wharton, K
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2005, 26 (06) : 1420 - 1424